1. GBD DALYs and HALE Collaborators. Global, regional, and national disability adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1260-344.
2.
Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012; 59: 991-7.
3.
Jeroudi OM, Alomar ME, Michael TT, et al. Prevalence and management of coronary chronic total occlusions in a tertiary veterans affairs hospital. Catheter Cardiovasc Interv 2014; 84: 637-43.
4.
Young MN, Secemsky EA, Kaltenbach LA, et al. Examining the operator learning curve for percutaneous coronary intervention of chronic total occlusions. Circ Cardiovasc Interv 2019; 12: e007877.
5.
Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv 2015; 8: 245-53.
6.
Azzalini L, Karmpaliotis D, Santiago R, et al. Contemporary issues in chronic total occlusion percutaneous coronary intervention. JACC Cardiovasc Interv 2022; 15: 1-21.
7.
Sapontis J, Salisbury AC, Yeh RW, et al. Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC Cardiovasc Interv 2017; 10: 1523-34.
8.
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
9.
Antoniades C, Antonopoulos AS, Deanfield J. Imaging residual inflammatory cardiovascular risk. Eur Heart J 2020; 41: 748-58.
10.
Goeller M, Achenbach S, Duncker H, et al. Imaging of the pericoronary adipose tissue (PCAT) using cardiac computed tomography: modern clinical implications. J Thorac Imaging 2021; 36: 149-61.
11.
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.
12.
Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-49.
13.
Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-6.
14.
Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1.
15.
Nerlekar N, Baey YW, Brown AJ, et al. Poor correlation, reproducibility, and agreement between volumetric versus linear epicardial adipose tissue measurement: a 3D computed tomography versus 2D echocardiography comparison. JACC Cardiovasc Imaging 2018; 11: 1035-6.
16.
Honold S, Wildauer M, Beyer C, et al. Reciprocal communication of pericoronary adipose tissue and coronary atherogenesis. Eur J Radiol 2021; 136: 109531.
17.
Akoumianakis I, Antoniades C. The interplay between adipose tissue and the cardiovascular system: is fat always bad? Cardiovasc Res 2017; 113: 999-1008.
18.
Morino Y, Abe M, Morimoto T, et al.; J-CTO Registry Investigators. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 2011; 4: 213-21.
19.
Alessandrino G, Chevalier B, Lefèvre T, et al. A clinical and angiographic scoring system to predict the probability of successful first-attempt percutaneous coronary intervention in patients with total chronic coronary occlusion. JACC Cardiovasc Interv 2015; 8: 1540-8.
20.
Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score. JACC Cardiovasc Interv 2016; 9: 1-9.
21.
Gorter PM, de Vos AM, van der Graaf Y, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008; 102: 380-5.
22.
Toma A, Gick M, Minners J, et al. Survival after percutaneous coronary intervention for chronic total occlusion. Clin Res Cardiol 2016; 105: 921-9.
23.
Khan MF, Wendel CS, Thai HM, et al. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion. Catheter Cardiovasc Interv 2013; 82: 95-107.
24.
Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol 2015; 115: 1367-75.
25.
Lee PH, Lee SW, Park HS, et al. Successful recanalization of native coronary chronic total occlusion is not associated with improved long-term survival. JACC Cardiovasc Interv 2016; 9: 530-8.
26.
Park JP, Han S, Sung KC, et al. Seven-year clinical outcomes of successful versus failed revascularization using drug-eluting stents for the treatment of coronary chronic total occlusion. J Invasive Cardiol 2016; 28: 229-36.
27.
Winther NS, Holck EN, Mogensen LJH, et al. Early and long-term prognosis in patients with remaining chronic total occlusions after revascularization attempt. A cohort study from the SKEJ-CTO registry. Scand Cardiovasc J 2023; 57: 17-24.
28.
Shuster A, Patlas M, Pinthus JH, et al. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 2012; 85: 1-10.
29.
Ansaldo AM, Montecucco F, Sahebkar A, et al. Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol 2019; 278: 254-60.
30.
Cherian S, Lopaschuk GD, Carvalho E. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Am J Physiol Endocrinol Metab 2012; 303: 937-49.
31.
Park JS, Choi SY, Zheng M, et al. Epicardial adipose tissue thickness is a predictor for plaque vulnerability in patients with significant coronary artery disease. Atherosclerosis 2013; 226: 134-9.
32.
Mahabadi AA, Lehmann N, Kälsch H, et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study. JACC Cardiovasc Imaging 2014; 7: 909-16.
33.
Qi XY, Qu SL, Xiong WH, et al. Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword. Cardiovasc Diabetol 2018; 17: 134.
34.
Xie Z, Zhu J, Li W, et al. Relationship of epicardial fat volume with coronary plaque characteristics, coronary artery calcification score, coronary stenosis, and CT-FFR for lesion-specific ischemia in patients with known or suspected coronary artery disease. Int J Cardiol 2021; 332: 8-14.
35.
Gać P, Macek P, Poręba M, et al. Thickness of epicardial and pericoronary adipose tissue measured using 128-slice MSCT as predictors for risk of significant coronary artery diseases. Ir J Med Sci 2021; 190: 555-66.
36.
Samy NI, Fakhry M, Farid W. Relation between epicardial adipose tissue thickness assessed by multidetector computed tomography and significance of coronary artery disease. World J Cardiovasc Dis 2020; 10: 91-101.
37.
Demircelik MB, Yilmaz OC, Gurel OM, et al. Epicardial adipose tissue and pericoronary fat thickness measured with 64-multidetector computed tomography: potential predictors of the severity of coronary artery disease. Clinics (Sao Paulo) 2014; 69: 388-92.
